Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay
Not Applicable
Completed
- Conditions
- Pancreatic Cancer
- Interventions
- Dietary Supplement: Oral Impact, Nestlé Health Science
- Registration Number
- NCT01789073
- Lead Sponsor
- University of Copenhagen
- Brief Summary
The purpose of this study is to investigate the effect of preoperative immunonutrition on complications and length of hospital stay in patients with pancreatic cancer undergoing elective surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- Men and women referred to treatment at Surgical Gastroenterology Clinic C, Ward 2122 for pancreatic cancer
- Age > 18 years.
Exclusion Criteria
- Age < 18 years
- Pregnant and lactating women
- Persons who cannot understand and/or speak Danish
- Renal dysfunction
- Milk allergy
- Participants are excluded if elective surgery is not indicated after all
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Oral Impact, Nestlé Health Science Oral Impact, Nestlé Health Science Oral Impact-arm receives the intervention the last 7 days prior to surgery
- Primary Outcome Measures
Name Time Method Overall postoperative complications after major gastrointestinal (GI) elective surgery. Within the first 30 days after surgery
- Secondary Outcome Measures
Name Time Method Length of hospital stay after major gastrointestinal (GI) elective surgery Within the first 30 days after surgery
Trial Locations
- Locations (1)
Surgical Gastroenterology Clinic C, Ward 2122, Rigshospitalet
🇩🇰Copenhagen, Denmark